investorscraft@gmail.com

Stock Analysis & ValuationSugi Holdings Co.,Ltd. (7649.T)

Professional Stock Screener
Previous Close
¥3,559.00
Sector Valuation Confidence Level
High
Valuation methodValue, ¥Upside, %
Artificial intelligence (AI)2830.47-20
Intrinsic value (DCF)26984.61658
Graham-Dodd Method1428.91-60
Graham Formula3598.291

Strategic Investment Analysis

Company Overview

Sugi Holdings Co., Ltd. is a leading Japanese drugstore chain, operating over 1,190 stores nationwide as of 2019. Headquartered in Obu, Japan, the company specializes in pharmaceutical retail, offering prescription and over-the-counter medications, health and beauty products, and daily necessities. Additionally, Sugi Holdings provides visiting nursing and home care support services, positioning itself as a comprehensive healthcare provider. Founded in 1976, the company has grown to become a key player in Japan's healthcare sector, benefiting from the country's aging population and increasing demand for accessible healthcare services. With a market capitalization exceeding ¥555 billion, Sugi Holdings is a significant contributor to Japan's pharmaceutical retail industry, leveraging its extensive store network and integrated healthcare services to maintain a competitive edge.

Investment Summary

Sugi Holdings presents a stable investment opportunity within Japan's healthcare sector, supported by its extensive retail network and diversified service offerings. The company's strong revenue of ¥878 billion and net income of ¥25.7 billion reflect its solid operational performance. With a low beta of 0.443, Sugi Holdings exhibits lower volatility compared to the broader market, appealing to risk-averse investors. The company's healthy operating cash flow of ¥36.9 billion and manageable debt levels further underscore its financial stability. However, investors should consider the competitive nature of Japan's drugstore market and potential regulatory changes impacting pharmaceutical retail. The dividend yield, supported by a ¥35 per share payout, adds to its attractiveness for income-focused portfolios.

Competitive Analysis

Sugi Holdings competes in Japan's highly fragmented drugstore market, where scale and location are critical success factors. The company's competitive advantage lies in its extensive store network, which ensures broad customer reach and brand recognition. Its integration of healthcare services, such as visiting nursing and home care support, differentiates it from pure-play retail competitors. However, Sugi Holdings faces intense competition from larger rivals like Matsumotokiyoshi and Tsuruha Holdings, which boast even more extensive networks and stronger bargaining power with suppliers. The company's focus on suburban and regional markets, as opposed to urban centers, allows it to capture underserved demographics but may limit growth in high-traffic areas. Additionally, Sugi Holdings' relatively smaller scale compared to industry leaders could hinder its ability to achieve the same economies of scale. Nevertheless, its consistent profitability and strategic service diversification position it well for sustained growth in Japan's aging society.

Major Competitors

  • Matsumotokiyoshi Holdings Co., Ltd. (3088.T): Matsumotokiyoshi is Japan's largest drugstore chain, with over 1,700 stores. Its extensive network and strong brand give it significant pricing power and supplier leverage. However, its focus on urban areas may limit growth in regional markets where Sugi Holdings has a stronger presence.
  • Tsuruha Holdings Inc. (3391.T): Tsuruha Holdings operates over 2,000 stores, making it one of Japan's top drugstore chains. Its scale allows for competitive pricing and robust private-label offerings. However, its aggressive expansion strategy has led to higher debt levels compared to Sugi Holdings.
  • Satudora Holdings Co., Ltd. (3544.T): Satudora is a mid-sized drugstore chain with a focus on Hokkaido and northern Japan. While it has a strong regional presence, its smaller scale limits its national competitiveness compared to Sugi Holdings.
  • Welcia Holdings Co., Ltd. (2659.T): Welcia, a subsidiary of Aeon, combines drugstore retail with supermarket offerings, providing a unique hybrid model. Its backing by Aeon enhances its financial stability, but its focus on urban centers may not directly compete with Sugi Holdings' regional strategy.
HomeMenuAccount